weekly-digest
Two themes cut across this week’s 236 posts. The first is de-escalation: researchers are building rigorous evidence that patients can safely do less — skip lymph node surgery, forgo radiotherapy, watch pre-invasive lesions instead of cutting them out. The landmark result here is a randomized trial confirming that active surveillance
project-idea
Analysis of 9,000+ patients revealed that only colorectal cancer — not other cancer types — consistently harbors distinct microbial communities, suggesting the gut microbiome has a unique relationship with colorectal carcinogenesis that could be exploited for diagnostics and treatment.
project-idea
Non-cancerous brain support cells were found to promote glioblastoma growth through paracrine signaling, and blocking this communication dramatically slowed tumor growth — revealing that GBM's microenvironment contains targetable vulnerabilities that are being systematically overlooked by drug…
project-idea
BRD2 and BRD4 have fundamentally distinct functions — BRD2 prepares genes for activation while BRD4 triggers transcription — meaning that pan-BET inhibitors have been disrupting gene regulation in counterproductive ways, and the field now needs selective BRD4 inhibitors.
project-idea
Zeaxanthin — a carotenoid supplement already taken for eye health — strengthens T cells and enhances immunotherapy effectiveness in preclinical models, suggesting that common dietary compounds may meaningfully modulate cancer immune responses and warrant systematic investigation.
project-idea
A randomized trial shows active surveillance for DCIS produces similar ipsilateral invasive breast cancer survival as immediate surgery — a landmark result that means thousands of women per year could potentially avoid surgery, but only if they can access clear information to make an informed…
project-idea
Significant incidental findings on lung screening CT are associated with a substantially increased risk of extrapulmonary cancer diagnosis in the following year — meaning lung screening programs are detecting signals for multiple cancer types, but follow-up infrastructure for incidental findings is…
project-idea
Pre-treatment MRI features provide independent prognostic information beyond PSA, Gleason grade, and clinical stage in prostate cancer — yet most existing risk calculators don't integrate MRI findings, creating a gap between what imaging tells us and how treatment decisions are made.
project-idea
The Physicians Committee for Responsible Medicine has petitioned the USDA to add colon cancer warning labels to processed meats — a science-backed public health intervention supported by WHO Group 1 carcinogen designation that lacks a centralized advocacy coordination resource.
project-idea
Post-mastectomy pain syndrome (PMPS) affects a significant subset of mastectomy patients with severe, prolonged neuropathic pain — yet it remains under-recognized, under-treated, and under-studied, partly because patients lack tools to track their symptoms and communicate their experience to…
project-idea
Therapy-related AML has tripled over 30 years as more cancer survivors live longer after genotoxic chemotherapy and radiation — yet patients and oncologists rarely have accessible tools to quantify this long-term risk when making treatment decisions or planning survivorship surveillance.
project-idea
GLP-1 receptor agonists and bariatric surgery are now proven effective obesity treatments with potential direct anti-cancer effects, but oncology practices and obesity medicine remain siloed — creating a coordination gap for the large fraction of cancer survivors with obesity.
